JSM 2004 - Toronto

JSM Activity #182

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
182 Tue, 8/10/04, 8:30 AM - 10:20 AM TCC-713 A
Statistical Applications in Medical Device Clinical Studies - Topic Contributed - Papers
Biopharmaceutical Section
Organizer(s): Lilly Yue, U.S. Food and Drug Administration
Chair(s): Lakshmi Vishnuvajjala, U.S. Food and Drug Administration
     8:35 AM   Bayesian Analysis of Mislabeling of Training Observations in Discriminant Analysis: Applications to Diagnostic Testing in the Medical Device Industry — Laura A. Thompson, U.S. Food and Drug Administration
     8:55 AM   Bayesian Methods for Combining Medical Device Studies under FDA Review — Gene A. Pennello, U.S. Food and Drug Administration
     9:15 AM   Practical Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies — Lilly Yue, U.S. Food and Drug Administration
     9:35 AM   Survival Analysis in Medical Device Clinical Studies with Heterogeneous Samples — Barbara Krasnicka, U.S. Food and Drug Administration; Chang S. Lao, U.S. Food and Drug Administration
     9:55 AM   Clinical Trial Analyzed with Cox Proportional Hazards Models (Stratified over Covariables) for Progression-Free and Overall Survival of Patients with a Progressive Disease — Harry F. Bushar, U.S. Food and Drug Administration
     10:15 AM   Floor Discussion
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004